Atracurium was administered by infusion to 12 anaesthetized patients undergoing cardiac surgery with cardiopulmonary bypass and induced hypothermia. Following an initial bolus dose of 0.6mgkg~', an infusion of atracurium was continued at an average rate of 0.0066 + 0.0003 mg kg~' min~' (0.4 mg kg~' h~') which was sufficient to maintain 90-95% block of the single twitch or train-of-four responses before bypass. Adequate surgical n»)aTarinn was provided with apjiimiman-ly half the rate of infusion of Endotracheal intubation was accomplished following the administration of a bolus dose of atracurium 0.6mgkg~' i.v. Before bypass, anaesthesia was maintained with 66% nitrous oxide in oxygen with increments of phenoperidine 1-2 mg, as required. Ventilation was adjusted to maintain normocarbia and any acid-base deficit of greater than -5mmollitre~' was corrected with appropriate amounts of 8.4% sodium bicarbonate. During bypass, perfusion pressure was maintain^ between 50 and 100 mm Hg using 1-mg increments of phentolamine or metaraminol i.v., as required. Arterial pressure, central venous pressure, heart rate, the
for mitral or aortic valve replacement, or both, and who had given their informed consent. The trial was conducted with the authority of a clinical trial certificate issued with the approval of the Committee on Safety of Medicines and the study was approved by the Ethics Committee of the London Hospital.
The patients were premedicated with papaveretum 15-20mg and hyoscine 0.3-0.4mg i.m. 1 h before surgery. Following arrival in theatre, a force transducer was strapped in the patient's left hand and attached to the thumb; an i.v. and an i.a. cannuia were inserted under local anaesthesia to a peripheral vein and a femoral artery, respectively. Following pre-oxygenation, anaesthesia was induced with phenoperidine 1-2 mg and thiopentone 200-400mg i.v. When the patient lost consciousness, needle electrodes were inserted adjacent to the ulnar nerve and a control recording of the responses of the adductor pollicis muscle to train-of-four or single twitch stimulation every 10 s was obtained. Endotracheal intubation was accomplished following the administration of a bolus dose of atracurium 0.6mgkg~' i.v. Before bypass, anaesthesia was maintained with 66% nitrous oxide in oxygen with increments of phenoperidine 1-2 mg, as required. Ventilation was adjusted to maintain normocarbia and any acid-base deficit of greater than -5mmollitre~' was corrected with appropriate amounts of 8.4% sodium bicarbonate. During bypass, perfusion pressure was maintain^ between 50 and 100 mm Hg using 1-mg increments of phentolamine or metaraminol i.v., as required. Arterial pressure, central venous pressure, heart rate, the electrocardiogram and peripheral and core temperatures were recorded.
When the initial twitch response had returned to between 5 and 10% of the control height an infusion of atracurium was begun. The concentration of the solution used for infusion was made up according to the patient's weight (i.e. kg x 10" 2 ) mgml" 1 diluted in normal saline (Eagar, Flynn and Hughes, 1984) . Studies have shown that, at concentrations of 0.6-0.9 mg ml" 1 , this solution remains stable at ambient temperature for at least 4h. The infusion was administered from a 50-ml syringe driven by a Vickers Treonic 3 Digital Syringe pump at rates which ranged from 10 to 60 ml h" 1 . The infusion was discontinued just before the completion of surgery. All patients were transferred to the intensive care unit and maintained on IPPV for at least 12 h. Results are presented as mean values (± SEM) and statistical analyses were carried out using Student's t tests.
RESULTS
The initial bolus dose of atracurium 0.6 mg kg" 1 i.v. provided satisfactory conditions for endotracheal intubation within 60-300 s(mean 130± 19.5s)after its administration. The maximum change in mean arterial pressure was ±10 mm Hg and in heart rate was ±10 beat min" 1 except in one patient in whom the heart rate increased by 27 beat min" 1 on intubation. Analysis of the results for the patient group did not show any changes of statistical significance.
In six patients, after the initial bolus dose of atracurium 0.6 mg kg" 1 , a mean time of 33 ± 3.9 min was required for 5-10% recovery of the first trainof-four response when the infusion was begun. Before bypass at a core temperature of 36-37 °C the individual infusion rates required to maintain 90-95% block of the first train-of-four response were varied between 0.0050 and 0.0100 mgkg^min" 1 according to the desired degree of peripheral neuromuscular blockade, and in response to the demands of surgery. The mean infusion rates ranged from 0.0050 to 0.0086mgkg" 1 min" 1 (average 0.0068 ±0.0006 mg kg" 1 min" 1 ) in the six patients studied (table I) . The commencement of cardiopulmonary bypass had no effect on the degree of neuromuscular blockade, but the train-of-four response disappeared abruptly during cooling to a core temperature of 25-26°C. In the first two patients, the infusion of atracurium was discontinued and about 30 min later, despite no response to train-of-four stimulation or to an applied tetanus (50 Hz for 5 s), the patients began to breathe spontaneously and the infusion was recommenced, but at a lower rate. In the remaining four patients in the group, as soon as hypothermia was established, the mean infusion rates were reduced by 34-51% and surgical relaxation was assessed clinically and judged to be adequate. During bypass, the individual infusion rates varied from 0.0017 to 0.0067 mg kg" 1 min" 1 and mean infusion rates from 0.0036 to 0.0045 mg kg" 1 min" 1 (average 0.0039 ±0.0002 mgkg"
1 min" 1 ) in the six patients studied (table  I) . Following cardiopulmonary bypass the individual infusion rates ranged from 0.0025 to ) and 0.0067 to 0.0100 mg kg" 1 min" 1 and the mean infurecovery began 25.7±2.0min following termination of the infusion. A typical tracing is shown in figure 1 .
In the other group of six patients, following the initial bolus dose of atracurium, the time taken for 5-10% recovery of the control single twitch response was 37 ±2.7 min; the infusion was then comsionratefrom0.0050to0.0078mgkg" 1 min~1(average 0.0065 ± 0.0004 mg kg" 1 min" 1 ) as shown in table II. During cardiopulmonary bypass with induced hypothermia the individual rates of infusion ranged from 0.0017 to 0.0067 mg kg" 1 min" 1 and the mean infusion rates were 0.0019 to 0.0050 mg kg" 1 min" 1 (average 0.0029 ±0.0005 mg kg" 1 min" 1 ). In four patients the single twitch response disappeared gradually during hypothermia, but it was possible to monitor the level of blockade by applying a tetanus (50 Hz for 5 s) periodically and counting the post-tetanic twitches. In two patients the twitch response was present throughout the period of bypass and induced hypothermia; a typical tracing is shown in figure 2. Following bypass, satisfactory surgical relaxation was provided by infusion rates of 0.0033 to 0.0067 mgkg" 1 min" 1 in these six patients. Mean infusion rates ranged from 0.0040 to 0.0067 mg kg" 1 min" 1 (average 0.00521 0.0004 mg kg" 1 min" 1 ) (table II) and the onset of recovery was seen within 9.5 min of discontinuing the infusion. DISCUSSION A bolus dose of atracurium 0.6 ing kg" 1 provided satisfactory surgical relaxation without affecting cardiovascular stability in 12 patients undergoing open-heart surgery. Since each patient was being treated for heart failure, a low cardiac output and slow circulation could account for the longer time taken to accomplish intubation in some of the patients compared with that reported in previous studies (Payne and Hughes, 1981; Scott and Goat, 1982).
Monitoring of neuromuscular blockade during hypothermia is complicated by the fact that cooling affects nervous conduction, neuromuscular transmission and muscular activity (Hodgkin and Katz, 1949; Hill, 1951; Katz and Miledi, 1965; Harris and Leach, 1968; Hubbard, Jones and Landau, 1971 ). Furthermore, the evoked response obtained in a peripheral muscle during cardiopulmonary bypass may be influenced by peripheral and core temperature gradients and alterations in skeletal muscle blood flow (Gazzaniga et al., 1972) .
In this study, the train-of-four response disappeared when hypothermia was rapidly induced to a core temperature of 26 °C. Although it has been reported that twitch height is reduced during cooling (Feldman, 1973) , the single twitch response was less affected by hypothermia and allowed a finer adjustment of the rates of infusion. These rates tended to be lower during bypass and higher following bypass than those obtained when train-of-four stimulation was used, although the differences be-tween these rates were not signifiranr (tables I and IT). It is likely that the train-of-four response was more affected by low temperature than the single twitch because synaptic activity is greater during train-of-four than single twitch stimulaton and acetylcholine release may be depressed by hypothermia (Feldman, 1979) . Furthermore, the difference observed between the single twitch and train-of-four responses suggests that hypothermia had a more pronounced effect at the neuromuscular junction relative to its effect on nervous conduction and muscle contraction.
The average infusion rate required to maintain surgical relaxation before bypass was similar to that used in patients undergoing prolonged general surgery (Eagar, Flynn and Hughes, 1984) , but during cardiopulmonary bypass with induced hypothermia a significant reduction of 45-55% (P<0.001) in the average infusion rates was obtained (tables I and II). Previous studies have shown that the action of competitive neuromuscular blocking agents is prolonged during hypothermia and cardiopulmonary bypass (Park and Macnamara, 1979). This effect has been attributed to a decrease in renal and hepatic clearance (Ham et al., 1978; Shanks and Walker, 1982) . However, the effect of hypothermia should be easier to assess with atracurium since its inactivation is mainly dependent on temperature and pH (Merrett, Thompson and Webb, 1983) . Our results agree well with the in vitro study of Merrett and co-workers, who showed that a decrease in temperature to 25°C doubled the halflife of atracurium, and in this study a similar decrease in core temperature allowed the average rate of infusion required to maintain surgical relaxation to be halved.
It is worth noting that the infusion rates required post-bypass were significantly lower (P<0.01; P< 0.001) than those used before bypass was commenced in the 12 patients studied (tables I and II). The after-decrease in both core and peripheral temperatures, which occurred following cardiopulmonary bypass (Flynn et al., 1983) , could reduce the rate of inactivation of atracurium, and may also depress neuromuscular function.
Thus, atracurium appeared to be suitable for use as an infusion in patients undergoing cardiac surgery and the temperature-dependent inactivation of atracurium was used to advantage because less drug was required during induced hypothermia.
